Pomona Ricerca

Pomona Ricerca S.r.l. is a private Italian R&D biotech company engaged to find solutions to important medical needs through the study of human broadly neutralizing antibodies. Pomona Ricerca’s focus centers on the concept of neutralizing antibodies, as defines by Nobel Prize winner Paul Ehrlich referred as ‘magic bullet’, to use as therapeutic biomolecules. Moreover, the exploration and analysis of neutralizing antibodies by Pomona enable the company to engage in the creation and advancement of cutting-edge epitope-based vaccines utilizing the anti-idiotype response strategy, commonly known as the anti-idiotype vaccine.